Italy signaled its intention to loosen the army’s grip on the cultivation of medical marijuana, considerably ramp up manufacturing and make MMJ “available in all pharmacies” throughout the nation.
The transfer additionally might improve alternatives for worldwide MMJ corporations collaborating within the nation’s medical cannabis business.
Italian Health Minister Giulia Grillo made the announcement in a Facebook submit after touring the Military Pharmaceutical Chemical Plant, which is the one licensed cultivator within the nation.
Italian regulation already permits the well being ministry to grant cultivation licenses to personal corporations, however this was the primary signal of political willingness to increase manufacturing by means of licensing public-private partnerships.
“The Italian authorities appear to realize that the government alone is not in a position to satisfy the quickly growing demand for medical cannabis in the country,” stated Pavel Pachta, a marketing consultant with International Cannabis and Cannabinoids Institute.
“This is an important change in the government policy, and it seems to be the first step towards the establishment of a commercial medical cannabis industry in Italy.”
Doctors in Italy have been in a position to prescribe marijuana since 2007.
However, the nation has suffered a medical cannabis scarcity for years, stemming from having only one home producer and a restricted variety of import licensees.
A authorities report offered to Marijuana Business Daily pegs near-term demand at 2,000 kilograms (four,409 kilos), because the nation is seeing a rise in cannabis prescriptions; army manufacturing tops out at about 250 kilograms per yr.
If the federal government follows by way of with the plan to discover public-private partnerships, curiosity from worldwide corporations shall be excessive.
“It is very positive from Italian patients’ perspective that the government will seek to broaden both the range of products available and reduce the cost incurred,” stated Stephen Murphy, managing director of United Kingdom-based Prohibition Partners. “It opens the door, but major question marks (remain) about how wide.”
Earlier this yr, two Canada-based corporations turned to acquisitions and provide agreements to enter the Italian market.
Toronto-based Nuuvera – now a subsidiary of Aphria – acquired considered one of solely seven corporations in Italy with a license to import medical cannabis.
The German subsidiary of Alberta-based Aurora Cannabis, Pedanios, gained an unique tender to provide 100 kilograms of medical marijuana to the Italian authorities.
Spectrum Cannabis, the European subsidiary of Canopy Growth (TSE: WEED), was additionally a finalist for the contract.
Matt Lamers may be reached at [email protected]
To join our weekly Canada marijuana enterprise publication, click on right here.